| scholarly article | Q13442814 |
| P50 | author | Danielle S W Benoit | Q79920245 |
| P2093 | author name string | Yuchen Wang | |
| Sue Zhang | |||
| P2860 | cites work | Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering | Q44130308 |
| Tailored drug release from biodegradable stent coatings based on hybrid polyurethanes | Q45447710 | ||
| The effect of ethylene glycol methacrylate phosphate in PEG hydrogels on mineralization and viability of encapsulated hMSCs. | Q46684159 | ||
| Diblock Copolymer Hydrophobicity Facilitates Efficient Gene Silencing and Cytocompatible Nanoparticle-Mediated siRNA Delivery to Musculoskeletal Cell Types. | Q47148640 | ||
| The Effects of Biological Fluids on Colloidal Stability and siRNA Delivery of a pH-Responsive Micellar Nanoparticle Delivery System | Q47258087 | ||
| Controlled and sustained delivery of siRNA/NPs from hydrogels expedites bone fracture healing | Q48030459 | ||
| Evaluating side effects of nanoparticle-mediated siRNA delivery to mesenchymal stem cells using next generation sequencing and enrichment analysis. | Q51008485 | ||
| Nanoscale physicochemical properties of chain- and step-growth polymerized PEG hydrogels affect cell-material interactions. | Q51041732 | ||
| Encapsulation of primary salivary gland cells in enzymatically degradable poly(ethylene glycol) hydrogels promotes acinar cell characteristics. | Q51063613 | ||
| The effect of heparin-functionalized PEG hydrogels on three-dimensional human mesenchymal stem cell osteogenic differentiation. | Q51135106 | ||
| Synthesis and characterization of a fluvastatin-releasing hydrogel delivery system to modulate hMSC differentiation and function for bone regeneration. | Q51157645 | ||
| Manipulations in hydrogel degradation behavior enhance osteoblast function and mineralized tissue formation. | Q51162848 | ||
| Serpine1 Knockdown Enhances MMP Activity after Flexor Tendon Injury in Mice: Implications for Adhesions Therapy. | Q55264094 | ||
| A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics | Q77642468 | ||
| Localized, targeted, and sustained siRNA delivery | Q83460693 | ||
| Dynamic manipulation of hydrogels to control cell behavior: a review | Q30424427 | ||
| Degradable hydrogels for spatiotemporal control of mesenchymal stem cells localized at decellularized bone allografts | Q33859464 | ||
| Hydrogels in pharmaceutical formulations | Q33935258 | ||
| Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibility | Q33957126 | ||
| RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo | Q34379366 | ||
| Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. | Q34535205 | ||
| Development of a novel endosomolytic diblock copolymer for siRNA delivery | Q35031634 | ||
| Development and in vitro assessment of enzymatically-responsive poly(ethylene glycol) hydrogels for the delivery of therapeutic peptides | Q35246152 | ||
| Hydrogels in Regenerative Medicine | Q35827832 | ||
| Enzymatically-responsive pro-angiogenic peptide-releasing poly(ethylene glycol) hydrogels promote vascularization in vivo | Q36225041 | ||
| Controlling mesenchymal stem cell gene expression using polymer-mediated delivery of siRNA | Q36408468 | ||
| Temporally tunable, enzymatically responsive delivery of proangiogenic peptides from poly(ethylene glycol) hydrogels | Q36418634 | ||
| Functionalized, biodegradable hydrogels for control over sustained and localized siRNA delivery to incorporated and surrounding cells | Q36428234 | ||
| Hydrogels in controlled release formulations: network design and mathematical modeling | Q36643019 | ||
| Nanoparticle-mediated gene silencing confers radioprotection to salivary glands in vivo | Q36915128 | ||
| Ubiquitin E3 ligase Wwp1 negatively regulates osteoblast function by inhibiting osteoblast differentiation and migration | Q37110197 | ||
| The effect of mesenchymal stem cells delivered via hydrogel-based tissue engineered periosteum on bone allograft healing | Q37224988 | ||
| Hydrogels for cardiac tissue regeneration | Q37344210 | ||
| PEG hydrogels for the controlled release of biomolecules in regenerative medicine | Q37352861 | ||
| Knocking down barriers: advances in siRNA delivery | Q37380671 | ||
| Delivery materials for siRNA therapeutics | Q38154803 | ||
| Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials | Q41029580 | ||
| Hydrolytically degradable poly(ethylene glycol) hydrogel scaffolds with tunable degradation and mechanical properties | Q42044239 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| hydrogel | Q898925 | ||
| P304 | page(s) | 58-66 | |
| P577 | publication date | 2018-08-03 | |
| P1433 | published in | Journal of Controlled Release | Q6295046 |
| P1476 | title | Degradable poly(ethylene glycol) (PEG)-based hydrogels for spatiotemporal control of siRNA/nanoparticle delivery | |
| P478 | volume | 287 |
Search more.